News , Next cohort 2 for phase 2 is starting which is mid-dose. Good news https://ih.advfn.com/stock-market/NASDAQ/axovant-sciences-ltd-AXGT/stock-news/79795007/axovant-announces-dosing-of-first-patient-in-secon